Early research (Phase 1)WithdrawnNCT01472848What this trial is testingGastrointestinal Tolerability Of PF05212389 In Obese SubjectsWho this might be right forObesity Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT07304843What this trial is testingA Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive DysfunctionWho this might be right forPrimary Biliary Cholangitis (PBC) Umecrine Cognition AB 84
Early research (Phase 1)Study completedNCT00389376What this trial is testingPhase I Trial of Silymarin for Chronic Liver DiseasesWho this might be right forHepatitis CNon-Alcoholic Fatty Liver Disease National Center for Complementary and Integrative Health (NCCIH) 56
Early research (Phase 1)Study completedNCT04844450What this trial is testingA Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795Who this might be right forFatty Liver Disease Janssen Research & Development, LLC 55
Early research (Phase 1)Active Not RecruitingNCT07713290What this trial is testingA Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma (HCC)Unresectable Hepatocellular Cancer Beijing Gene Key Life Technology Co., Ltd 6
Testing effectiveness (Phase 2)Study completedNCT02267525What this trial is testingThe Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) StudyWho this might be right forGastroparesis Theravance Biopharma 233
Early research (Phase 1)Study completedNCT01258205What this trial is testingMultiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease SubjectsWho this might be right forCrohn's Disease AstraZeneca 48
Not applicableUnknownNCT05293353What this trial is testingNeokare Safety and Tolerability Assessment in Neonates With GI ProblemsWho this might be right forNECGastroschisisIntestinal Perforation+8 more University Hospital Southampton NHS Foundation Trust 50
Early research (Phase 1)Study completedNCT04643795What this trial is testingPhase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control SubjectsWho this might be right forHepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver Madrigal Pharmaceuticals, Inc. 87
Early research (Phase 1)Not Yet RecruitingNCT07760077What this trial is testingPhase I Study of QLS1510 Tablets in Healthy ParticipantsWho this might be right forInflammatory Bowel Disease (IBD) Shanghai Qilu Pharmaceutical Research and Development Center LTD 90
Testing effectiveness (Phase 2)Study completedNCT02718495What this trial is testingStudy Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic FibrosisWho this might be right forCystic Fibrosis Proteostasis Therapeutics, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00820365What this trial is testingSC12267 (4SC-101) for Treatment of Patients With Inflammatory Bowel DiseaseWho this might be right forInflammatory Bowel Disease (IBD) 4SC AG 34
Large-scale testing (Phase 3)Ended earlyNCT01538251What this trial is testingEfficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative ColitisWho this might be right forUlcerative Colitis sigma-tau i.f.r. S.p.A. 147
Early research (Phase 1)Looking for participantsNCT06440005What this trial is testingEvaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsWho this might be right forCancerAdvanced CancerLocally Advanced Carcinoma+8 more Angiex, Inc. 80
Post-approval studies (Phase 4)Study completedNCT01838772What this trial is testingHCV Treatment in HIV Co-Infected Patients in AsiaWho this might be right forHepatitis CHIV amfAR, The Foundation for AIDS Research 188
Testing effectiveness (Phase 2)Study completedNCT01386112What this trial is testingSafety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic EsophagitisWho this might be right forEosinophilic Esophagitis Forest Laboratories 24
Early research (Phase 1)Ended earlyNCT02659631What this trial is testingPF-06671008 Dose Escalation Study in Advanced Solid TumorsWho this might be right forNeoplasms Pfizer 28
Large-scale testing (Phase 3)Study completedNCT02273167What this trial is testingMulticenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus MOVIPREP® Using 2-Day Split-Dosing and 1-Day Morning Split-Dosing Regimen in Adults.Who this might be right forColorectal CancerColorectal CarcinomaColon Cleansing Norgine 849
Early research (Phase 1)Study completedNCT00846131What this trial is testingY-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Northwestern University 24
Testing effectiveness (Phase 2)Study completedNCT07108153What this trial is testingProof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaWho this might be right forCystic Fibrosis (CF) Sionna Therapeutics Inc. 15